Unraveling the synergy of radiotherapy and immune checkpoint inhibitors in NSCLC: emerging clinical evidence and novel therapeutic strategies
Bibliographic record
Abstract
Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality worldwide. While immune checkpoint inhibitors (ICIs) continue to redefine the therapeutic paradigm, their efficacy is limited to a specific proportion of patients. Radiotherapy (RT) is proposed as a strategy to enhance their efficacy, yet its clinical impact remains unclear, hindered by its double-edged sword effect on the immune system across variable settings. This review explores the landscape of RT-ICI combinations in NSCLC, analyzing available evidence in the light of current treatment guidelines. The presented data provide a foundation to validate computational models to predict clinical outcomes and inform tumor-immune dynamics. ClinicalTrials.gov was queried for trials involving both modalities, excluding studies incorporating other therapies except chemotherapy and surgery, other cancer types, or brain metastases. Of the 309 trials identified, 23 met the inclusion criteria, encompassing resectable (n=3), early-stage (n=3), locally advanced (n=10), and advanced NSCLC (n=7). In the neoadjuvant setting, the combination achieves a remarkable pathological response without significantly affecting surgical outcomes. Long-term survival benefit remains elusive. In early-stage unresectable tumors, ICIs are poised to replace chemotherapy as the preferred peri-radiation systemic treatment to prevent recurrences. Current data on locally advanced NSCLC confirm the feasibility of early ICI introduction, chemotherapy-free regimens, and individualized RT approaches. A definitive risk-benefit balance has yet to be established. In advanced stages, while the abscopal effect is well documented, statistical significance remains a concern, necessitating adequately designed studies powered to identify subpopulations most likely to benefit from the combination. Innovative, feasible approaches include RT and dual ICI, re-irradiation beyond progression, multisite micro-radiation, or partial irradiation of large tumors to activate a "hot" tumor microenvironment. In conclusion, while the combination of RT and ICI holds promise, significant challenges remain. A deeper understanding of immune dynamics is crucial. Additionally, the complexity of trial design, coupled with a lack of statistical significance in most available data, underscores the need for more phase 3 trials, the development of powerful biomarkers, and complementary approaches, such as virtual clinical trials, to accelerate progress and refine treatment strategies.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.003 | 0.004 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.002 | 0.002 |
| Bibliometrics | 0.001 | 0.001 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.002 | 0.002 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.001 | 0.002 |
| Insufficient payload (model declined to judge) | 0.005 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".